|
|
| Word Search |
Vectura finds bearing in post-Advair era with GSK deal
(August 06, 2010)
|
| Which big pharma remains hostage to blockbuster fortune?
(July 22, 2010)
|
Theravance Reports Second Quarter 2010 Financial Results
Theravance
(July 22, 2010)
|
GSK Announces Q2 Results for 2010
GlaxoSmithKline
(July 21, 2010)
|
Abbott's Progress Study of Kaletra and Isentress Compared With a Standard HIV Regimen Meets The Pre-Specified Primary Efficacy Endpoint
Abbott Laboratories
(July 19, 2010)
|
| FDA deals Merck and SkyePharma different hands on asthma drugs
(June 24, 2010)
|
| New LABA warnings unlikely to make big players pause for breath
(June 03, 2010)
|
GSK Announces Revised Product Labels for Serevent® and Advair®
GlaxoSmithKline
(June 02, 2010)
|
| Humira set to steal Avastin’s crown
(May 03, 2010)
|
Abbott Receives FDA Approval for Once-Daily Dosing of Kaletra® ( lopinavir / ritonavir ) for Treatment-Experienced Patients
Abbott Laboratories
(April 28, 2010)
|
|
|
|
|
|
|
|